Healthcare resource savings from administering paliperidone palmitate once every 3 months instead of once every month for schizophrenia: a 12-month mirror-image analysis of real-world population-based data
Transitioning from PP1M to PP3M for schizophrenia treatment can significantly reduce healthcare resource utilization and costs. Notably, hospitalization and emergency room visit costs were reduced by approximately half.
Authors
- Chuan-Sheng Hung (ORCID: https://orcid.org/0009-0008-6290-0967)
- Jui-Hsiu Tsai
- Ke-Fei Wu
- Ya-Hui Yang
- Hung-Yi Chuang
Institutions
- National Taichung University of Science and Technology (TW)
- National Sun Yat-sen University (TW)
- Kaohsiung Medical University (TW)
- Tzu Chi University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Buddhist Tzu Chi Medical Foundation (US)
- Cheng Shiu University (TW)
Publication Details
- Journal
- Therapeutic Advances in Psychopharmacology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1177/20451253261419626
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00